The role of ETV2 in lymphangiogenesis potentially has functional implications in LAM as there are lymphatic manifestations in LAM, including increased expression of VEGF-D in the serum of LAM patients (Seyama et al, 2006; Glasgow et al, 2008; Young et al, 2010). This evidence concerns the gene ETV2 and lymphangioleiomyomatosis.